Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
The Power of Non Traditional KOL Engagement
Summary
In this episode, Tom Caravela is joined by Lindsey Harrer to discuss the power of non traditional Key Opinion Leader (KOL) engagement for Medical Science Liaisons (MSLs). They explore the differences in KOL interactions, strategies for aligning MSL objectives with KOL needs, and the importance of personalized communication. The conversation highlights compliance challenges in nontraditional KOL engagement and its future potential. Lindsey shares insights on applying nontraditional approaches in interviews and MSL strategies, emphasizing the importance of empathy in connecting with healthcare professionals on a human level. The episode concludes with closing remarks and expressions of gratitude.
Key Points
- Nontraditional KOL engagement focuses on understanding healthcare providers' challenges and needs from a deeply human perspective.
- Genuine curiosity and active listening are essential in building meaningful relationships and creating tailored solutions for healthcare providers.
- Partnering with compliance and legal teams from the outset ensures innovative initiatives are implemented effectively and within regulatory guidelines.
Nontraditional KOL engagement, Medical Science Liaisons strategies, personalized communication in healthcare, compliance in KOL interactions, empathy in healthcare relationships
Related Topics
You May Also Like
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Podcast
Michael Pietrack
Hiring Managers Beware: Reverse Rejection Explained!
Article
Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Forbes Books Press Release Official
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
Podcast
MSL Talk: Tom Caravela, Josh Corriveau